Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 347 of the 347 references it cites were found in a registry or an index; 9 of the 272 sources its claims cite were checked for support.

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

Open access
Kooij, Sandra JJ, Bejerot, Susanne, Blackwell, Andrew, Caci, Herve, Casas-Brugué, Miquel, Carpentier, Pieter J, Edvinsson, Dan, Fayyad, John, Foeken, Karin, Fitzgerald, Michael, Gaillac, Veronique, Ginsberg, Ylva, Henry, Chantal, Krause, Johanna, Lensing, Michael B, Manor, Iris, Niederhofer, Helmut, Nunes-Filipe, Carlos, Ohlmeier, Martin D, Oswald, Pierre, Pallanti, Stefano, Pehlivanidis, Artemios, Ramos-Quiroga, Josep A, Rastam, Maria, Ryffel-Rawak, Doris, Stes, Steven, Asherson, Philip · 2010 · BMC Psychiatry

Abstract

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe. METHODS: The European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe. This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated. RESULTS: Besides information on the genetics and neurobiology of ADHD, three major questions are addressed in this statement: (1) What is the clinical picture of ADHD in adults? (2) How can ADHD in adults be properly diagnosed? (3) How should ADHD in adults be effectively treated? CONCLUSIONS: ADHD often presents as an impairing lifelong condition in adults, yet it is currently underdiagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group.

Overview

CoChat Summary

TL;DR

This European consensus statement concludes that ADHD often persists into adulthood, is underdiagnosed and undertreated in many European countries, and can be diagnosed with available instruments and treated with multimodal care, especially stimulants. It synthesizes expert consensus and literature to guide adult ADHD diagnosis and treatment across Europe.

Key findings

  • ADHD persists into adulthood in around two-thirds of childhood cases; in a meta-analysis, about 15% retained the full diagnosis by age 25 years and a further 50% were in partial remission. Adult prevalence is estimated at 2–5%.
  • In adult clinical samples, comorbidity is the rule: 75% have at least one other disorder, with a mean of three psychiatric comorbidities; around 20% of parents of children with ADHD have ADHD themselves.
  • Stimulants are first-choice treatment and are effective in about 70% of patients in controlled studies; atomoxetine is second line with an effect size of around 0.4. The 6-item ASRS screener had sensitivity 68.7%, specificity 99.5%, and total classification accuracy 97.9% in population survey data, but in a substance-use-disorder sample sensitivity was 87.5% and specificity 68.6%.
  • Heritability is around 76% on average in child/adolescent twin studies, while adult self-rated population twin samples report lower estimates of 30–40%; first-degree relatives have a 20–50% prevalence, and candidate gene findings explain around 3.2% of variance in children.

Methods

  • Consensus statement from the European Network Adult ADHD, founded in 2003, including 40 professionals from 18 European countries; developed through three meetings between 2003 and 2009 and circulated for written approval by network members.
  • Evidence was assembled from Medline, Embase, and the Cochrane Database, including reviews and randomised controlled trials in adults, reviews on ADHD in children, cross-referencing, and identification by participating experts; clinical presentation was further informed by clinical expertise.
  • The statement addresses three major questions: the clinical picture of ADHD in adults, how to properly diagnose ADHD in adults, and how to effectively treat ADHD in adults.

Limitations

  • The paper states that more research is needed in adults; no neurobiological or neuropsychological tests have sufficient sensitivity and specificity for individual diagnosis; psychological treatments lack an evidence base sufficient to recommend routine use; and validation of translated instruments and age-, gender-, and IQ-matched reference values are needed.
  • The paper states that lower adult self-rated heritability estimates (30–40%) are not fully explained and that no empirical data resolve these questions, so further work is needed.
  • Evident from the text: this is an expert consensus statement rather than a systematic review or meta-analysis, and recommendations rely on consensus and clinical experience; competing interests are disclosed for many authors.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1471-244x-10-67

Cites

347 of 347 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 2 Not valid · 105 Not checked · 38 Own results and interpretations

64 more claims · 2 with their cited sources checked

Create a free account to see all 153 claims and to verify the 263 references still open.

See all claims — free account
  • It may state two separate claims as one. 75
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 336 references

Research works printed but not linked: 11

  1. Faraone SV, Doyle AE, Knoerzer JA: Heritability of attention-deficit/hyperactivity disorder. Economics of Neuroscience. 2001, 3 (5): 54-57.
  2. Kessler RC: Comorbidity patterns in a community sample of adults with ADHD: results from the National Comorbidity Survey Replication. APA 160th Annual Meeting. 2007
  3. Faraone SV, Sergeant J, Gillberg C: The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry. 2003, 2: 104-113.
  4. Murphy K, Barkley RA: Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. ComprPsychiatry. 1996, 37 (6): 393-401.
  5. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007, 190: 402-409. 10.1192/bjp.bp.106.034389. · DOI · Paper page
  6. Nadeau KG, Quinn PO: Understanding women with AD/HD. 2002, Silver Spring: Advantage Books
  7. Barkley RA: Age dependent decline in ADHD: True recovery or statistical illusion?. The ADHD Report. 1997, 5: 1-5.
  8. Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ: An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. J Subst Abuse Treat. 2006, 30 (3): 253-259. 10.1016/j.jsat.2005.12.004. · DOI · Paper page
  9. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, et al: The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005, 35 (2): 245-256. 10.1017/S0033291704002892. · DOI · Paper page
  10. Conners CK, Erhardt D, Sparrow E: Conners Adult ADHD Rating Scales (CAARS). Technical Manual. 1999, New York: Multi Health Systems Inc
  11. Epstein JN, Johnson DE, Conners CK: CAADID. The Conner's Adult ADHD Diagnostic Interview for DSM-IV. 2001, MHS Inc

Cited by

See all 928

Metadata

Authors
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., Gaillac, V., Ginsberg, Y., Henry, C., Krause, J., Lensing, M. B., Manor, I., Niederhofer, H., Nunes-Filipe, C., Ohlmeier, M. D., Oswald, P., Pallanti, S., Pehlivanidis, A., Ramos-Quiroga, J. A., Rastam, M., Ryffel-Rawak, D., Stes, S., & Asherson, P.
Affiliations
  • Karolinska Institutet (SE)
  • Addenbrooke's Hospital (GB)
  • Reinier van Arkel (NL)
  • Uppsala University (SE)
  • University of Balamand (LB)
  • Trinity College Dublin (IE)
  • Centre Hospitalier Charles Perrens (FR)
  • Oslo University Hospital (NO)
  • Tel Aviv University (IL)
  • Ospedale di Bolzano (IT)
  • Medizinische Hochschule Hannover (DE)
  • Université Libre de Bruxelles (BE)
  • University of Florence (IT)
  • National and Kapodistrian University of Athens (GR)
  • KU Leuven (BE)
  • King's College London (GB)
Venue
BMC Psychiatry
Published
2010-09-03
Volume
10
Issue
1
Pages
67-67
ISSN
1471-244X (ISSN-L)
OpenAlex
W2137706707
Cited by
928
References
336
Citations by year
2026: 40 · 2025: 60 · 2024: 42 · 2023: 43 · 2022: 47 · 2021: 46 · 2020: 72 · 2019: 77 · 2018: 60 · 2017: 67 · 2016: 70 · 2015: 67 · 2014: 87 · 2013: 66 · 2012: 54
FWCI
32.58
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion, other-oa)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Research Portal (King's College London) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion, other-oa)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
  • Apollo (cc-by)
Funders
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
  • Teva Pharmaceutical Industries
  • National Institute for Health and Care Research (RP-PG-0606-1045)
  • Lunds Universitet
  • National and Kapodistrian University of Athens
  • Medizinischen Hochschule Hannover
  • Universidade de Lisboa
  • Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu
  • H. Lundbeck A/S
  • National Institutes of Health
  • Medical Research Council
  • Menzies Centre for Australian Studies, King's College London, University of London
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
adult ADHD, attention deficit hyperactivity disorder, diagnosis, treatment, clinical picture, underdiagnosis, screening tool, neurobiology, economic burden
MeSH terms
Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Combined Modality Therapy, Europe, Female, Humans, Male, Psychotherapy, Practice Guidelines as Topic, Disease Progression, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. https://app.cochat.ai/papers/10.1186/1471-244x-10-67
The paper
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., Gaillac, V., Ginsberg, Y., Henry, C., Krause, J., Lensing, M. B., Manor, I., Niederhofer, H., Nunes-Filipe, C., Ohlmeier, M. D., . . . Asherson, P. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. https://doi.org/10.1186/1471-244x-10-67

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.